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The Haemophilus influenzae HMW1C Protein Is a
Glycosyltransferase That Transfers Hexose Residues to
Asparagine Sites in the HMW1 Adhesin
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Abstract
The Haemophilus influenzae HMW1 adhesin is a high-molecular weight protein that is secreted by the bacterial two-partner
secretion pathway and mediates adherence to respiratory epithelium, an essential early step in the pathogenesis of H.
influenzae disease. In recent work, we discovered that HMW1 is a glycoprotein and undergoes N-linked glycosylation at
multiple asparagine residues with simple hexose units rather than N-acetylated hexose units, revealing an unusual Nglycosidic linkage and suggesting a new glycosyltransferase activity. Glycosylation protects HMW1 against premature
degradation during the process of secretion and facilitates HMW1 tethering to the bacterial surface, a prerequisite for
HMW1-mediated adherence. In the current study, we establish that the enzyme responsible for glycosylation of HMW1 is a
protein called HMW1C, which is encoded by the hmw1 gene cluster and shares homology with a group of bacterial proteins
that are generally associated with two-partner secretion systems. In addition, we demonstrate that HMW1C is capable of
transferring glucose and galactose to HMW1 and is also able to generate hexose-hexose bonds. Our results define a new
family of bacterial glycosyltransferases.
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are cleaved by signal peptidase I [18]. The resulting pro-proteins
are targeted to the HMW1B and HMW2B outer membrane
translocators and undergo cleavage between amino acids 441 and
442, removing the pro-pieces and generating mature species that
are 125 kDa and 120 kDa, respectively [18–21] (Figure 1A).
Following translocation across the outer membrane, mature
HMW1 and HMW2 remain non-covalently associated with the
bacterial surface [18,19].
In recent work, we demonstrated that HMW1 is a glycoprotein
and undergoes glycosylation in the cytoplasm in a process that is
dependent upon HMW1C [22]. Functional analyses revealed that
glycosylation of HMW1 protects against premature degradation,
analogous to some eukaryotic proteins [22]. In addition,
glycosylation appears to influence HMW1 tethering to the
bacterial surface, a prerequisite for HMW1-mediated adherence
[22]. Based on carbohydrate composition analysis of purified
HMW1 using gas chromatography and combined gas chromatography-mass spectrometry, the modifying sugars include glucose,
galactose, and possibly small amounts of mannose [22]. Analysis of
HMW1 proteolytic fragments by mass spectrometry identified 31
sites of modification [23]. All of the modified sites were asparagine
residues, in all except one case within the conventional sequence
motif for eukaryotic N-linked glycosylation, namely NX(S/T)
where X is any residue except for proline [23]. LC-MS/MS
analysis, accurate mass measurement, and deuterium replacement

Introduction
Glycosylation of proteins is an essential process that plays an
important role in protein structure and function and represents a
strategy to fine tune cell-cell recognition and signaling. For a long
period of time, glycosylation of proteins was believed to be
restricted to eukaryotes. However, in recent years glycoproteins
have been identified increasingly in prokaryotes as well, including
pathogenic bacteria such as Pseudomonas aeruginosa, Campylobacter
spp., Neisseria spp., and E. coli, among others [1–10].
Nonencapsulated (nontypable) Haemophilus influenzae is a human
specific pathogen that is a common cause of localized respiratory
tract and invasive disease and initiates infection by colonizing the
upper respiratory tract [11,12]. Approximately 75–80% of isolates
express two related high-molecular weight proteins called HMW1
and HMW2 that mediate high-level adherence to respiratory
epithelial cells and facilitate the process of colonization [13,14].
The HMW1 and HMW2 adhesins are encoded by homologous
chromosomal loci that appear to represent a gene duplication
event and contain 3 genes, designated hmw1A, hmw1B, and hmw1C
and hmw2A, hmw2B, and hmw2C, respectively [15,16].
HMW1 and HMW2 are synthesized as pre-pro-proteins
(Figure 1A) and are secreted by the two-partner secretion system
[17–19]. Amino acids 1–68 represent an atypical signal peptide
and direct the pre-pro-proteins to the Sec apparatus, where they
PLoS Pathogens | www.plospathogens.org
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cluster is capable of transferring glucose and galactose to the
HMW1 adhesin. In addition, HMW1C is capable of generating
hexose-hexose linkages.

Author Summary
Decoration of proteins with carbohydrates has an important impact on protein function throughout biology and
has been recognized increasingly in pathogenic bacteria.
Haemophilus influenzae is a common cause of both
bacterial respiratory tract disease and bacterial invasive
disease and initiates infection by colonizing the upper
respiratory tract. The Haemophilus HMW1 adhesin is a large
protein that resides on the bacterial surface and mediates
bacterial attachment to respiratory epithelial cells, an
essential step in the process of colonization. In recent
work, we discovered that HMW1 is decorated at multiple
sites with short carbohydrate units that serve to prevent
degradation and to stabilize association with the bacterial
surface. In the current study we identify the enzyme
responsible for adding carbohydrate units at specific sites
of HMW1. In addition, we demonstrate that this enzyme is
capable of creating both carbohydrate-protein and carbohydrate-carbohydrate bonds. The amino acid sequence of
this enzyme is similar to the sequences of proteins in
several other bacteria, suggesting a new family of bacterial
enzymes capable of creating carbohydrate-protein and
carbohydrate-carbohydrate bonds.

Results
HMW1C is a glycosyltransferase
In earlier work we found that insertional inactivation of hmw1C
in H. influenzae strain Rd-HMW1 resulted in a loss of
glycosylation of HMW1 [22], suggesting that HMW1C participates in the process of glycosylation. Further analysis revealed that
amino acids 386–439 in HMW1C share 40–41% identity and 51–
65% similarity with a domain conserved in a family of eukaryotic
O-GlcNAc transferases, including human O-GlcNAc transferase,
rat O-GlcNAc transferase, and a plant protein called Spy [22],
raising the possibility that HMW1C is a glycosyltransferase.
To address the possibility that HMW1C is the glycosyltransferase responsible for N-linked glycosylation of HMW1, we purified
HAT-tagged HMW1C and Strep-tagged HMW1802–1406
(Figure 1B). HMW1802–1406 corresponds to just over half of
mature HMW1 (HMW1442–1536), contains 18 documented Nlinked glycosylation sites, and was more amenable to purification
than mature HMW1 (Figure 1A). Subsequently, we incubated
approximately equimolar quantities of HAT-HMW1C and StrepHMW1802–1406 with both UDP-a-D-glucose and UDP-a-Dgalactose at room temperature for 60 minutes, then examined
the reaction mixture for reactivity with the DIG-glycan reagents.
As shown in Figure 2A, we observed efficient glycosylation of
HMW1802–1406 that was dependent on both HMW1C and the
UDP-hexoses. To extend this result, we performed the same
experiment with UDP-a-D-glucose by itself, UDP-a-D-galactose
by itself, GDP-a-D-mannose by itself, UDP-a-D-N-Acetylglucosamine by itself, and UPD-a-D-N-Acetylgalactosamine by itself.
As shown in Figure 2B, we observed glycosylation with UDP-a-Dglucose alone and UDP-a-D-galactose alone but not with GDP-a-

studies established that the modifying glycan structures were
mono-hexose or di-hexose units rather than N-acetylated
hexosamine units that comprise the di-N-diacetyl chitobiose core
of eukaryotic and many bacterial asparagine-linked glycans. These
results suggested a novel N-linked carbohydrate-peptide transferase activity that does not require assembly of the monosaccharide
units onto a lipid-linked intermediate [23].
In the present study, we studied the enzymatic mechanism
responsible for the glycosylation of asparagine residues in HMW1.
We found that the HMW1C protein encoded in the hmw1 gene

Figure 1. Purified proteins for examination of glycosylation of HMW1. Panel A shows a schematic of the HMW1 pre-pro-protein. The white
bar represents the signal peptide, corresponding to amino acids 1–68. The gray bar represents the pro-piece, corresponding to amino acids 69–441.
The black bar represents the mature protein, corresponding to amino acids 442–1536. The vertical ticks above the black bar represent sites of Nlinked glycosylation. The portion of HMW1 that was used as the acceptor protein for in vitro glycosyltransferase assays is highlighted by the bracket
and corresponds to amino acids 802–1406 and contains 18 sites of glycosylation. Panel B shows Coomassie blue-strained gels of purified streptagged HMW1802–1406 and purified HAT-tagged HMW1C.
doi:10.1371/journal.ppat.1000919.g001
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Figure 2. In vitro transferase assays, examining samples by SDS-PAGE and detecting glycosylation with DIG-glycan reagents. Panel A
shows results with various combinations of purified HMW1802–1406, purified HMW1C, and UDP-a-D-glucose plus UDP-a-D-galactose. Panel B shows
results with purified HMW1C, purified HMW1802–1406, and either UDP-a-D-glucose, UDP-a-D-galactose, GDP-a-D-mannose, UDP-a-D-NAcetylglucosamine, or UPD-a-D-N-Acetylgalactosamine.
doi:10.1371/journal.ppat.1000919.g002

D-mannose, UDP-a-D-N-Acetylglucosamine, or UPD-a-D-NAcetylgalactosamine alone. To determine whether smaller
amounts of HMW1C are associated with appreciable glycosylation
of HMW1802–1406, we repeated assays with a fixed amount of
HMW1802–1406, fixed amounts of UDP-a-D-glucose and UDP-aD-galactose, and dilutions of HMW1C. Based on analysis using
DIG-glycan reagents, we observed efficient glycosylation with
molar quantities of HMW1C that were less than one-tenth the
molar quantity of HMW1802–1406 (data not shown).

MS/MS. As a positive control we examined purified HMW1802–
1406 recovered from DH5a/pASK-HMW1802–1406 + pHMW1C,
and as a negative control we examined HMW1802–1406 recovered
from DH5a/pASK-HMW1802–1406 (lacking pHMW1C).
As summarized in Table 1, we detected 10 of the 18 predicted sites
of glycosylation and 11 distinct glycopeptides in HMW1802–1406,
including 10 glycopeptides with a single site of glycosylation and one
glycopeptide with two sites of glycosylation (KNITFEGGNITFGSR).
Interestingly, of the 10 sites of glycosylation, all were modified in the
in vitro reactions with UDP-a-D-glucose alone and with UDP-a-Dglucose plus UDP-a-D-galactose plus GDP-a-D-mannose. In
contrast, only 6 of the 10 sites of glycosylation were modified in the
in vitro reactions with UDP-a-D-galactose alone. Consistent with our
observations using DIG-Glycan reagents, no sites were glycosylated
in the in vitro reactions with GDP-a-D-mannose alone.
As demonstrated by the collision-induced fragmentation
spectra shown in Figure 3 and Figure S1, the glycopeptide
NLSITTNSSSTY (HMW1 amino acids 946–958, with glycosylation at N952) and the glycopeptide AITNFTFNVGGLFDNK (HMW1 amino acids 909–924, with glycosylation
at N912) were present in two forms, including one with a mono-

LC-MS/MS analysis of HMW1 after in vitro glycosylation
demonstrates specificity of glycosylation with glucose
versus galactose
To address whether the glycosylation of HMW1802–1406 in in
vitro reactions mimicked glycosylation of native HMW1 in whole
bacteria and to gain further insight into which sugars modify
which sites, we repeated reactions with purified Strep-tagged
HMW1802–1406, purified HAT tagged HMW1C, and UDP-a-Dglucose alone, UDP-a-D-galactose alone, GDP-a-D-mannose
alone, or UDP-a-D-glucose plus UDP-a-D-galactose plus GDPa-D-mannose and then examined the reaction mixtures by LCPLoS Pathogens | www.plospathogens.org

3

May 2010 | Volume 6 | Issue 5 | e1000919

H. influenzae HMW1C Is a Glycosyltransferase

Table 1. Glycopeptides detected in in vitro glycosylation assays with HMW1802–1406.

Sequence*

observed m/z

calculated m/z

Reactions yielding glycopeptide{

LTQDLNISGFNK

756.3823

756.383

Glu, Gal, Glu/Gal/Man

TIISGNITNK

611.8281

611.8299

Glu,Glu, Gal, Glu/Gal/Man

KNITFEGGNITFGSR

982.9750

982.976

Glu,Glu, Glu/Gal/Man

NVTVNNNITSHK

751.87476

751.8759

Glu,Glu, Gal, Glu/Gal/Man

AGVDGENSDSDATNNANLTIK

1134.5079

1134.5091

Glu,Glu, Gal, Glu/Gal/Man

AITNFTFNVGGLFDNK

960.4725

960.4729

Glu,Glu, Gal, Glu/Gal/Man

AITNFTFNVGGLFDNK

1041.4988

1041.4993

Glu,Glu, Glu/Gal/Man

NGDLNITNEGSDTEMQIGGDVSQK

1342.5945

1342.5956

134 Glu, Glu/Gal/Man

NLSITTNSSSTYR

803.3851

803.3838

Glu,Glu, Gal, Glu/Gal/Man

NLSITTNSSSTYR

884.4091

884.4102

Glu,Glu, Glu/Gal/Man

EGNLTISSDK

613.2985

613.2933

613.Glu, Glu/Gal/Man

*Underlined residues represent hexosylated sites, and boldfaced residues represent dihexosylated sites.
{Glu represents UDP-a-D-glucose, Gal represents UDP-a-D-galactose, and Glu/Gal/Man represents UDP-a-D-glucose plus UDP-a-D-galactose plus GDP-a-D-mannose.
doi:10.1371/journal.ppat.1000919.t001

Inactivation of galU eliminates glycosylation of HMW1

hexose at the predicted site of glycosylation and the other with a
di-hexose at the predicted site of glycosylation. The forms
containing a mono-hexose were detected in the in vitro
reactions with UDP-a-D-glucose alone, UDP-a-D-galactose
alone, and UDP-a-D-glucose plus UDP-a-D-galactose plus
GDP-a-D-mannose, while the forms containing a di-hexose
were detected only in the in vitro reactions with UDP-a-Dglucose alone and with UDP-a-D-glucose plus UDP-a-Dgalactose plus GDP-a-D-mannose, suggesting that glucose must
be the first hexose linked to asparagine in the glycopeptides
containing di-hexose modification.
Together these findings demonstrate that the HMW1C protein
is a glycosyltransferase and has a novel activity capable of
transferring glucose and galactose to asparagine residues in
HMW1 and creating hexose-hexose bonds. In addition, they
demonstrate that the di-hexosylated sites at N951 and N912 are
initially modified with a glucose monosaccharide.

To extend our understanding of glycosylation of HMW1 and
confirm our observation that HMW1 is modified with glucose and
galactose in in vitro glycosylation assays, we examined the effect of
insertional inactivation of galU (open reading frame HI0812 in
strain Rd) on glycosylation of HMW1 in strain Rd-HMW1. The
galU gene encodes glucose-1-phosphate uridyl transferase, which
converts glucose-1-phosphate to UDP-glucose (Figure S2). UDPglucose in turn can be converted directly to UDP-galactose by
GalE (UDP Gal-4-epimerase) or can serve as the donor of UDP
for conversion of galactose-1-phosphate to UDP-galactose. In
assessing the effect of inactivation of galU, we incubated RdHMW1/galU in supplemented brain heart infusion broth [24],
which contains glucose as the primary carbon source. Interestingly, inactivation of galU mimicked the effect of inactivation of
hmw1C described in our earlier work [22], eliminating HMW1
glycosylation as assessed by DIG-glycan blots (Figure 4A), virtually

Figure 3. Collision-induced fragmentation spectra from glycosylated peptide NLSITTNSSSTYR (HMW1 amino acids 946–958). Panel
A shows the CID spectrum of the glycopeptide that is modified with one hexose unit. Panel B shows the CID spectrum of the glycopeptide that is
modified with a di-hexose. The asterisks indicate b and y fragmentation ions that underwent a neutral loss of one (*) or two (**) hexosyl residues.
doi:10.1371/journal.ppat.1000919.g003
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Figure 4. Effect of inactivation of the galU gene. Panel A shows purified HMW1 recovered from strain Rd-HMW1 and Rd-HMW1/galU. With strain
Rd-HMW1, HMW1 was recovered from the surface of whole bacteria. With strain Rd-HMW1/galU, HMW1 was recovered from the culture supernatant
and concentrated, reflecting the fact that HMW1 is no longer surface associated in this strain. Purified protein was resolved by SDS-PAGE and was
then either stained with Coomassie blue (upper gel) or examined for glycosylation using DIG-glycan reagents (lower gel). Panel B shows flow
cytometry results with strains Rd-HMW1, Rd-HMW1/hmw1C, and Rd-HMW1/galU using antiserum GP85 against HMW1 to detect surface-associated
HMW1. The number in the upper right corner of the plots of Rd-HMW1/hmw1C and Rd-HMW1/galU represents the percentage of surface-associated
HMW1 in strain Rd-HMW1. Panel C shows in vitro adherence results comparing adherence by Rd-HMW1, Rd-HMW1/hmw1C, and Rd-HMW1/galU to
Chang epithelial cells. Bars and error bars represent mean and standard deviations of measurements performed in triplicate.
doi:10.1371/journal.ppat.1000919.g004

transfer of oligosaccharides from a lipid-linked intermediate by an
oligosaccharyltransferase complex [25]. In Archaea, the mechanisms of N-glycosylation are less well understood. Glycosylation of
asparagine residues with a trisaccharide moiety in the flagellin and
S-layer proteins of Methanococcus voltae has been proposed to
proceed via a lipid-linked intermediate [26]. More recently it has
been shown that hexose units are attached directly to asparagine
residues in an S layer glycoprotein of Haloferax volcanii [27]. A
pentasaccharide with the structure Hex-X-hexuronic acid-HexAHexA-Hex-peptide was identified at two glycosylation sites.
Interestingly, these two sites were different from the conventional
N-glycosylation sequence motif observed in eukaryotes and in
HMW1. It is currently unclear whether the H. volcanii Hex-Asn
linkage is formed from a lipid-linked intermediate or via activated
monosaccharides as we have found with HMW1 and HMW1C.
In earlier work, we performed carbohydrate composition
analysis on purified HMW1 and detected glucose, galactose, and
small amounts of mannose [22]. Given the potential for
contaminating sugars to be detected in this analysis, we were
uncertain as to whether mannose was truly present as a modifying
sugar in HMW1, especially given that it accounted for only 2.5–

eliminating HMW1 tethering to the bacterial surface (Figure 4B),
and abolishing HMW1-mediated adherence (Figure 4C).
Consistent with our in vitro glycosyltransferase assays with
purified HMW1802–1406 and HMW1C, these results indicate that
UDP-glucose is required for glycosylation of HMW1 in H.
influenzae under standard growth conditions in supplemented brain
heart infusion broth.

Discussion
In this study, we found that the H. influenzae HMW1C protein
encoded in the hmw1 gene cluster is a glycosyltransferase and is
capable of transferring glucose and galactose to asparagine
residues in the HMW1 adhesin, providing the first example of a
glycosyltransferase that transfers hexose units rather than Nacetylated amino sugars to asparagine residues in protein targets.
Further analysis revealed that HMW1C is capable of creating both
hexose-asparagine and hexose-hexose linkages, suggesting multifunctionality as a glycosyltransferase.
All previously reported carbohydrate modification of asparagine
residues in proteins in Eukarya and Bacteria involve the en bloc
PLoS Pathogens | www.plospathogens.org
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To summarize, in eukaryotes N-linked glycosylation occurs in
the endoplasmic reticulum and involves an oligosaccharyltransferase that catalyzes the transfer of the oligosaccharide from the lipid
donor dolichylpyrophosphate to the acceptor protein. Similarly, in
bacteria, N-glycosylation generally occurs in the periplasm and
involves an oligosaccharyltransferase that transfers the glycan
structure from a lipid donor to the acceptor protein. In contrast, in
the case of the H. influenzae HMW1 adhesin, N-linked glycosylation occurs in the cytoplasm and involves direct transfer of hexose
units to the acceptor protein by HMW1C, with no requirement for
a lipid donor. In this study, we have established that the H.
influenzae HMW1C protein is a multi-functional enzyme that is
capable of transferring glucose and galactose to asparagine
residues in selected conventional N-linked sequence motifs in
HMW1 and is also capable of creating hexose-hexose linkages.
Based on homology analysis, it is likely that a variety of other
bacteria possess HMW1C-like proteins with similar enzymatic
activity. In future work, we will examine whether these HMW1Clike proteins are identical to HMW1C in terms of the glycan units
that they transfer and the acceptor protein sequence motifs that
they recognize.

3% of the total carbohydrate [22]. Our analysis in the current
study argues that mannose is not present in HMW1. In particular,
in in vitro glycosyltransferase assays using purified HMW1802–1406,
HMW1C, and GDP-a-D-mannose, we were unable to detect
modification of HMW1802–1406 using either DIG-Glycan reagents
or LC-MS/MS.
Based on assessment of the 10 glycopeptides that we detected in
our in vitro glycosylation assays with HMW1802–1406, which
corresponds to just over half of mature HMW1, we observed that
HMW1C transfers glucose to all glyscosylated asparagines and
transfers galactose to only a subset of glyscosylated asparagines. All
of these glycosylation sites correspond to the conventional
sequence motif of N-linked glycans, namely NX(S/T), with X
being any amino acid except proline. Examination of the primary
amino acid sequence of the sites that are modified only with
glucose and the sites that are modified with either glucose or
galactose in in vitro assays reveals no apparent distinction,
suggesting that factors beyond the amino acid sequence influence
the specificity or potentially the efficiency of glycosylation. This
observation is consistent with the fact that only a fraction of
conventional sequences motifs are glycosylated in HMW1 purified
from H. influenzae [23].
Further analysis of the glycopeptides detected after in vitro
glycosylation revealed two peptides that were modified with a dihexose. Interestingly, in both cases the glycopeptides were detected
only in the reactions performed with UDP-a-D-glucose alone and
with UDP-a-D-glucose plus UDP-a-D-galactose plus GDP-a-Dmannose, indicating modification with UDP-a-D-glucose. In
contrast, the corresponding glycopeptides containing a single
hexose at the asparagines in question were detected in the
reactions performed with UDP-a-D-glucose alone, with UDP-aD-galactose alone, and with UDP-a-D-glucose plus UDP-a-Dgalactose plus GDP-a-D-mannose, indicating modification with
either glucose or galactose. Considered together, these results
suggest that glucose must be linked to asparagine in the
glycopeptides containing di-hexose modification. At this point, it
is unclear whether the di-hexose is generated prior to modification
of the acceptor asparagine residue or whether instead a single
hexose is linked to the target asparagine and then a second hexose
is linked to the first hexose, although the conventional interpretation is that the hexose is added to the protein and then the chain
is extended. In either event, it appears that HMW1C is responsible
for creating the hexose-hexose bond.
Interestingly, homology analysis reveals 42–68% identity and
58–83% similarity between the full-length HMW1C sequence and
proteins in a number of other gram-negative bacterial pathogens,
including the enterotoxigenic E. coli (ETEC) EtpC protein and
predicted proteins in Yersinia pseudotuberculosis, Y. enterocolitica, Y.
pestis, H. ducreyi, Actinobacillus pleuropneumoniae, Mannheimia spp.,
Xanthomonas spp., and Burkholderia spp, among others (Table S1). In
ETEC, Y. pseudotuberculosis, Y. enterocolitica, and Y. pestis, these
homologs are encoded by genes that are adjacent to known or
predicted two-partner secretion loci. The H. ducreyi, Mannheimia
succiniciproducens, and Burkholderia xenovorans genomes contain genes
that encode predicted two-partner secretion proteins as potential
targets for the HMW1C homologs, although these genes are in
unlinked locations. The ETEC EtpC protein is encoded by a twopartner secretion locus called etpBAC and has been shown to be
required for glycosylation of the EtpA adhesin, a high-molecular
weight protein that has a predicted molecular mass of ,177 kDa
and promotes adherence to intestinal epithelial cells and
colonization of the intestine in mice [28,29]. These observations
suggest that that there is a family of bacterial HMW1C-like
proteins with glycosyltransferase activity.
PLoS Pathogens | www.plospathogens.org

Materials and Methods
Bacterial strains and plasmids
The strains and plasmids used in this study are listed in Table 2.
H. influenzae strain Rd-HMW1 is a derivative of strain Rd that
contains the intact hmw1 locus and expresses fully functional
HMW1 [22]. H. influenzae strain Rd-HMW1/hmw1C is a
derivative of strain Rd-HMW1 that contains an insertionally
inactivated hmw1C gene [22]. The H. influenzae Rd-HMW1
derivative harboring a kanamycin cassette in galU was constructed
by transforming competent Rd-HMW1 with genomic DNA
recovered from RdgalU and selecting for kanamycin resistance
[30].
In order to overexpress HMW1802–1406 with a Strep tag at the N
terminus, the fragment encoding HMW1802–1406 was amplified by
PCR from pHMW1-14 using a 59 primer that incorporated a
BamHI site and a 39 primer that incorporated a SalI site. The
PCR amplicon was digested with BamI and SalI and then ligated
into BamHI-SalI-digested pASK-IBA12 (IBA, BioTAGnology),
creating pASK-HMW1802–1406.
In order to overexpress the HMW1C protein with a HAT
epitope at the N terminus, the hmw1C gene was amplified by PCR
from pHMW1-14 using a 59 primer that incorporated a BamHI
site and a 39 primer that incorporated an EcoRI site. The PCR
amplicon was digested with BamHI and EcoRI and then ligated
into BamHI-EcoRI-digested pHAT10 (Clontech), creating pHATHMW1C.

Transformation and mutagenesis
Plasmids were introduced into E. coli by chemical transformation [31]. DNA was introduced into H. influenzae using the MIV
method of transformation described by Herriott et al. [32].
Transformants were selected by plating on agar containing
kanamycin, and mutations were confirmed by PCR analysis using
primers that anneal to regions flanking the target gene.

Protein purification
To purify HMW1802–1406, E. coli strain DH5a/pASKHMW1802–1406 was grown at 37uC to an OD600 of 0.7, then
induced for 2 hrs with the addition of 100 mg/ml of anhydrotetracycline (Sigma). Cells were harvested, resuspended in 100
mM Tris pH 8.0, 150 mM NaCl with Complete Mini protease
6
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Table 2. Strains and plasmids used in this study.

Strains

Description

Source/Reference

H. influenzae
Rd

Non-adherent non-encapsulated laboratory strain, formerly type d

Rd-HMW1

Derivative of Rd containing hmw1 locus and expressing HMW1

22

Rd-HMW1/hmw1C

Derivative of Rd-HMW1 with KanR cassette in hmw1C

22

Rd-HMW1/galU

Derivative of Rd-HMW1 with KanR cassette in galU

This study

E. coli
DH5a

E. coli F- F80dlacZDM15 D (lacZYA-argF) U169 deoR recA1 endA1 hsdR17(rK-mK+) phoA supE441 thi-1 gyrA96 relA1 28

Plasmids

Description

Source

pUC18

Cloning vector

pUC4K

Cloning vector

pASK-IBA12

Cloning vector

IBA, BioTAGnology

pASK-HMW1802–1406

Derivative of pASK-IBA12 encoding HMW1802–1406 with an N-terminal streptactin tag

This study

pHAT10

Cloning vector

Clontech

pHAT-HMW1C

Derivative of pHAT10 encoding HMW1C with an N-terminal HAT epitope

This study

Pharmacia

doi:10.1371/journal.ppat.1000919.t002

Resource Center using a Becton Dickinson FACS Calibur
instrument at a wavelength of 488 nm. Bacterial suspensions were
fixed with 1% formaldehyde in PBS at room temperature for
30 min. After washing once with Tris buffered saline (TBS),
bacteria were resuspended in 1 ml of TBS, 50 mM EDTA, 0.1%
bovine serum albumin, and a 1:1000 dilution of guinea pig
antiserum GP85 directed against HMW1 [33] and were incubated
with gentle rocking at room temperature for 1 hr. Samples were
then centrifuged, washed twice with PBS, and resuspended in
200 ml of PBS, 0.1% bovine serum albumin, and a 1:200 dilution
of Alexa Fluor488 anti-guinea pig antibody (Molecular Probes).
Samples were incubated with gentle rocking at room temperature
for 1 hr. After two additional washes with PBS, bacterial pellets
were re-suspended in 1 ml of PBS and were then analyzed. Data
were analyzed with CELLQUEST software (Becton Dickinson).
To quantify histograms, markers were drawn on plots, and positive
events within the markers were determined as a percentage of the
positive control (set at 100%).

inhibitor (Roche), and lysed by sonication. Insoluble material was
removed by centrifugation at 12,500 6 g for 30 min. The
supernatant was loaded onto a Strep-Tactin Superflow cartridge
and eluted according to the manufacturer’s instructions (IBA,
BioTAGnology). Eluted fractions were analyzed for purity by
SDS-PAGE and were pooled. To purify HMW1C, E. coli strain
DH5a/pHAT-HMW1C was grown at 37uC overnight. Cells were
recovered, resuspended in 50 mM sodium phosphate buffer
pH 7.0, 300 mM NaCl (bufferA), and lysed by sonication.
Insoluble material was removed by centrifugation at 12,500 6 g
for 30 min. The supernatant was loaded onto a 1 ml Talon
column (Clontech) and eluted with a gradient of 0 to 300 mM
imidazole in Buffer A. Fractions were analyzed for purity by SDSPAGE and were pooled.

Glycosyltransferase assay
In standard in vitro glycosyltransferase assays, 1.5 mg (23 pmole)
of purified HMW1802–1406 was combined with a mixture
containing 20 ml of 50 mM UDP-a-D-glucose, 50 mM UDP-aD-galactose, 50 mM GDP-a-D-mannose, 50 mM UDP-a-D-NAcetylglucosamine, or 50 mM UDP-a-D-N-acetylgalactosamine
(Calbiochem) either as individual sugars or as mixtures. The
reactions were initiated with addition of 1.5 mg (21 pmole) of
purified HMW1C in a final volume of 150 ml in 25 mM Tris
pH 7.2, 150 mM NaCl. Samples were incubated for 60 minutes at
room temperature and then further incubated at 4uC overnight.

Adherence assays
Adherence assays were performed with Chang epithelial cells
(human conjunctiva; ATCC CCL 20.2) (Wong-Kilbourne derivative clone 1-5c-4) as described previously [16]. Percent adherence
was calculated by dividing the number of adherent colony-forming
units by the number of inoculated colony-forming units. All strains
were examined in triplicate, and each assay was repeated at least
two times.

Carbohydrate detection
Protein analysis

To detect protein glycosylation, DIG Glycan reagents (Roche)
were employed. Use of these reagents is based on the oxidation of
hydroxyl groups in carbohydrates to aldehydes either in solution
or bound to nitrocellulose membranes. Digoxigenin is then
covalently linked to the aldehyde groups, and an anti-digoxigenin
alkaline-phosphatase conjugated agent is used for detection of
labeled carbohydrates.

Whole cell sonicates were prepared by suspending bacterial
pellets in 10 mM HEPES, pH 7.4 and sonicating to clarity.
Proteins were resolved by SDS-PAGE using 10% polyacrylamide
gels. Western blots were performed using guinea pig antiserum
GP85 against the HMW1 protein [30].

Protein digestion and peptide preparation
Flow cytometry

Samples were precipitated using the 2D protein clean up kit
(GE Healthcare) according to the manufacturer’s instructions.
Bovine serum albumin (100 ng) was added to each sample as an

FACS analysis was performed by the Duke University Medical
Center Cancer Research Center Flow Cytometry Shared
PLoS Pathogens | www.plospathogens.org
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internal standard. Pellets were dissolved in 40 ml 9 M urea and
aliquoted into 0.5 ml microfuge tubes. Samples (20 ml in 9 M urea)
were reduced with 5 mM TCEP at pH 8.0 at room temperature
for 30 min and were alkylated with 10 mM iodoacetamide (BioRad) in the dark at room temperature for 30 min. TCEP and
iodoacetamide were quenched with 5 mM dithiothreitol (DTT) at
room temperature for 10 min. The reduced and alkylated proteins
were digested with 1 mg of endoproteinase Lys-C (Roche) at 37uC
overnight. Samples were diluted with 64 ml H2O to reduce the
concentration of urea to 2 M and were then digested with 4 mg
trypsin (Sigma) at 37uC overnight. Peptides were acidified with 5.5
ml formic acid (Sigma) and extracted 6 times with 10–200 ml
NuTip porous graphite carbon wedge tips (Glygen) according to
the manufacturer’s directions and were then eluted into 1.5 ml
autosampler vials with 60% acetonitrile (Burdick & Jackson) in
0.1% formic acid. The peptide digests were evaluated for quality
and detergent contaminants using MALDI-TOF/TOF [34] prior
to LC-MS analysis. For MALDI-TOF/TOF analysis, the peptide
sample (0.5 ml) was mixed with an equal volume of MALDI matrix
solution (Agilent Technologies) prior to spotting. For nano-LCFTICR-MS analysis, the peptide sample was dried and immediately dissolved in 10 ml aqueous acetonitrile/formic acid (1%/1%).

using MASCOT Distiller (Matrix Science, version 2.3.0.0) with
the settings previously described [35]. The resulting MS2
centroided files were used for database searching with MASCOT,
version 2.1.6, and the following parameters: enzyme, trypsin; MS
tolerance = 10 ppm; MS/MS tolerance = 0.8 Da with a fixed
carbamidomethylation of Cys residues and the following variable
modifications: Methionine, oxidation; Pyro-glu (N-term); Maximum Missed Cleavages = 5; and 1+, 2+, and 3+ charge states.

Supporting Information
HMW1C homologs and potential TpsA and TpsB
partners.
Found at: doi:10.1371/journal.ppat.1000919.s001 (0.03 MB
DOC)

Table S1

Collision-induced fragmentation spectra of glycosylated peptide AITNFTFNVGGLFDNK (HMW1 amino acids
909–924). Panel A shows the CID spectrum of the glycopeptide
that is modified with one hexose unit, and Panel B shows the CID
spectrum of the glycopeptide that is modified with a di-hexosyl
moiety. The asterisks indicate b and y fragmentation ions that
underwent a neutral loss of one (*) or two (**) hexosyl residues. A
prominent ion that is consistent with the neutral loss of a hexosyl
unit was observed as the doubly charged species ([M+2H-81]+2).
In the spectrum from the mono-hexosylated glycopeptide (Panel
A), both y ions (y3, y4, y5, y6, y7, y8, y10, y11, y12, and y13 at m/z
376.3, 523.3, 636.3, 693.3, 750.4, 849.3, 1110.6, 1211.6, 1358.3,
and 1634.8, respectively) and b ions (b4, b5, b6, b8, b9, b12, b13, b14,
and b15 at m/z 562.1, 709.25, 810.3, 1071.6, 1170.4, 1397.4,
1544.7, 1659.5, and 1773.4, respectively) were observed that were
consistent with the amino acid sequence and hexosylation at N912
(y13 is the fragment ion modified with a hexose moiety). In the
spectrum from the di-hexosylated glycopeptide (panel B), a similar
pattern of neutral loss y and b ions was observed. The base peak in
this spectrum (m/z 960.3) represents loss of a single hexose moiety
from the doubly charged parent ion ([M+2H-81]2+), and a peak
representing loss of both hexose residues ([M+2H-162]2+) is also
seen (m/z 879.3). Several of the hexose-containing y ions and b
ions demonstrated neutral loss of a hexosyl residue, with one
hexosyl unit remaining on the y ion fragmentation series (y13* and
y14* at m/z 1635.0 and 1735.9, respectively) and b ion
fragmentation series (b4*, b5*, b6*, b9*, and b12* at m/z 562.3,
709.3, 810.2, 1170.4, and 1397.4, respectively). The deduced
amino acid sequence was supported by other unmodified y ions
(y3, y4, y5, y6, y7, y8, y9, y10, and y11 at m/z 376.1, 523.3, 636.3,
693.4, 750.3, 849.4, 963.3, 1110.5, and 1211.42, respectively).
Found at: doi:10.1371/journal.ppat.1000919.s002 (0.51 MB
TIF)
Figure S1

Mass spectrometry
The complex mixtures of peptides and glycopeptides from
HMW1802–1406 were analyzed using high-resolution nano-LC-MS
on a hybrid mass spectrometer consisting of a linear quadrupole iontrap and an Orbitrap (LTQ-Orbitrap XL, Thermo-Fisher). The
liquid chromatographs were nanoflow HPLC systems (NanoLC1DplusTM and NanoLC-UltraTM) that were interfaced to the mass
spectrometer with a nanospray source (PicoView PV550; New
Objective). The in-house packed LC column (Jupiter C12 Proteo,
4 mm particle size, 90 Å pore size [Phenomenex]) was equilibrated
in 98% solvent A (aqueous 0.1% formic acid) and 2% solvent B
(acetonitrile containing 0.1% formic acid). The samples (10 mL)
were injected from autosampler vials using the LC-systems
autosamplers at a flow rate of 1.0 mL/min and were eluted using
a segmented linear gradient (250 nL/min) with solvent B: isocratic
at 2% B, 0–2 min; 2% B to 40% B, 2–65 min; 40% B to 80% B, 65–
70 min; isocratic at 80% B, 70–72 min; 80% B to 2% B, 72–77 min;
and isocratic at 2% B, 77–82 min. The survey scans (m/z 350–2000)
(MS1) were acquired at high resolution (60,000 at m/z = 400) in the
Orbitrap, and the MS/MS spectra (MS2) were acquired in the
linear ion trap at low resolution, both in profile mode. The
maximum injection times for the MS1 scan in the Orbitrap and the
LTQ were 50 ms and 100 ms, respectively. The automatic gain
control targets for the Orbitrap and the LTQ were 26105 and
36104, respectively. The MS1 scans were followed by six MS2
events in the linear ion trap with wideband collision activation in the
ion trap (parent threshold = 1000; isolation width = 2.0 Da;
normalized collision energy = 30%; activation Q = 0.250; activation time = 30 ms). Dynamic exclusion was used to remove selected
precursor ions (20.25/+1.5 Da) after MS2 acquisition with a repeat
count of 2, a repeat duration of 30 s, and a maximum exclusion list
size of 200. The following ion source parameters were used:
capillary temperature 200 uC, source voltage 2.5 kV, source current
100 mA, and the tube lens at 79 V. The data were acquired using
Xcalibur, version 2.0.7 (Thermo-Fisher).
The MS2 spectra were analyzed both by searching a customized
protein database that contained the sequences of HMW802–1406
and by expert manual interpretation. The exact masses of the
glycopeptides and fragmentation ions were calculated using the
Molecular Weight Calculator, version 6.45 (http://ncrr.pnl.gov/
software/). For database searches, the LC-MS files were processed

PLoS Pathogens | www.plospathogens.org

The pathway for glucose and galactose metabolism in H.
influenzae. GalU (G-1-P uridylyltransferase) converts glucose-1-phosphate to UDP-glucose, which in turn is converted to UDP-galactose by
GalE (UDP-Gal-4-epimerase) and which also serves as a donor of UDP
for conversion of galactose-1-phosphate to UDP-galactose.
Found at: doi:10.1371/journal.ppat.1000919.s003 (0.06 MB TIF)

Figure S2
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